Burow Kristina's Form 4 filing
Neumora Therapeutics, Inc. (NMRA) · filed Nov 7, 2023
- Accession no.
- 0001062993-23-020280
- Filed
- Nov 7, 2023
- Trade date
- Nov 3-7, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $1.10M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burow KristinaCIK 0001569248 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | Common Stock | PPurchaseAcquired | +22,420 | $11.38 | +$255,139.6 | 3,882,318 | Indirect | |
| Nov 6, 2023 | Common Stock | PPurchaseAcquired | +43,082 | $11.55 | +$497,597.1 | 3,925,400 | Indirect | |
| Nov 7, 2023 | Common Stock | PPurchaseAcquired | +30,192 | $11.50 | +$347,208 | 3,955,592 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.